Cogent Biosciences (COGT) Times Interest Earned (2025 - 2026)

Cogent Biosciences (COGT) has reported Times Interest Earned for 10 consecutive years, with -$15.18 the latest figure, recorded in Q1 2026.

• In Q1 2026, Times Interest Earned rose 99.92% year-over-year to -$15.18; the TTM figure through Mar 2026 stood at -$53.03 (up 99.93% YoY), while the FY2025 annual figure was -$0.45, up 64.66% from the prior year.
• Times Interest Earned advanced to -$15.18 in Q1 2026 per COGT's latest filing, from -$78.84 in the prior quarter.
• Across five years, Times Interest Earned topped out at -$0.92 in Q2 2022 and bottomed at -$18733.2 in Q1 2025.
• Historically, Times Interest Earned has averaged -$1426.3 across 5 years, with a median of -$78.84 in 2025.
• Annual changes were most pronounced in 2023 — Times Interest Earned slumped 48721.25% — and 2026, when it soared 99.92%.
• Cogent Biosciences' Times Interest Earned stood at -$111.88 in 2022, then soared by 56.04% to -$49.18 in 2023, then soared by 59.07% to -$20.13 in 2024, then tumbled by 291.65% to -$78.84 in 2025, then surged by 80.75% to -$15.18 in 2026.
• Business Quant data shows COGT's Times Interest Earned at -$15.18 in Q1 2026, -$78.84 in Q4 2025, and -$14.5 in Q3 2025.